In 2017, a nomination was received to establish a whole genome sequencing service using Massively Parallel Sequencing (MPS). MPS is a new technology for whole exome or whole genome sequencing and has a range of applications in the prenatal, neonatal, paediatric and adult settings.
In 2017, a nomination was received to establish a service for Whole Genome Sequencing (WGS) for children with intellectual disability. The Committee recommended that additional advice be sought.
In 2019 an update was received on whole genome sequencing, which may be used to diagnose different forms of mitochondrial disease.
New health technology enquiries can be emailed to: MOH-HealthTechNominations@health.nsw.gov.au